Skip to content
Adjuvant Therapy in Renal Cell Carcinoma episode artwork

Dec 4, 2019 32 min

Adjuvant Therapy in Renal Cell Carcinoma

from AUAUniversity Hosted by American Urological Association

Co-Host: Alexander Kutikov, MD, FACS At the conclusion of these activities, participants will be able to: 1. Discuss the evolving landscape of adjuvant therapy for the treatment of RCC. 2. Identify best practices for risk assessment and patient selection for adjuvant RCC therapy. 3. Differentiate the roles of urologist and medical oncologist in the care of patients with RCC. CME Available: auau.auanet.org/node/26087 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Adjuvant Therapy in Renal Cell Carcinoma

0:00 32:06

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of AUAUniversity?

This episode is 32 minutes long.

When was this AUAUniversity episode published?

This episode was published on December 4, 2019.

Can I download this AUAUniversity episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.